Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 700 participants.
Also called NCT07687485
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 700 participants
- Sponsor
- Laplace Interventional, Inc
- Registry
-
NCT07687485
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07687485. Randomized; single masking; primary purpose treatment. Start 2026-09-04 (actual); primary completion 2029-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System
- Acronym
- TRIUMPH
- Condition
- Severe Tricuspid Valve Regurgitation
- Condition
- Tricuspid Valve Regurgitation
- Condition
- Tricuspid Valve Disease
- Condition
- Cardiovascular Diseases (CVD)
- Condition
- Heart Valve Diseases
- Condition
- Tricuspid Valve Insufficiency
- Condition
- Severe Heart Valve Disease
- Condition
- Symptomatic Tricuspid Regurgitation
- Intervention (Device)
- Transcatheter Tricuspid Valve Replacement (TTVR) with Laplace TTVR System
- Intervention (Device)
- Transcatheter Tricuspid Valve Replacement (TTVR) with Edwards EVOQUE TTVR System
- Lead sponsor
- Laplace Interventional, Inc
Record details
- Record id
cardio:ct-nct07687485- Content hash
8a6dc64b702928805906245433e15c155997c92a7971160b30785fb8ed65ab38